Skip to content
by Legal Desire
11 April 2024

Linklaters advises on Neopharmed Gentili’s debut high yield offering, the largest refinancing of private credit debt with high yield bonds in Europe to date

Advising firms

Deal team

19 lawyers named
LawyerFirmSeniorityPracticeOffice
Giacomo Reali Lead Linklaters Partner high yield Not stated
Chris Medley Lead Linklaters Partner banking London
Rohan Saha Lead Linklaters Partner banking London
Roberto Egori Lead Linklaters Partner tax Not stated
Adriana Perez Cavazos Linklaters Senior associate high yield Not stated
Dami Banire Linklaters Associate high yield Not stated
Filippo Turci Linklaters Trainee high yield Not stated
Diego Esposito Linklaters Partner banking Milan
Marco Carrieri Linklaters Counsel banking Milan
Giulia Oradei Linklaters Associate banking Not stated
Omer Harel Linklaters Counsel tax Not stated
Fabio Balza Linklaters Counsel tax Not stated
Eugenia Severino Linklaters Other tax Not stated
Allan Paul Talde Linklaters Not stated tax Not stated
Ugo Orsini Linklaters Partner Not stated Milan
Lucio D'Amario Linklaters Partner Not stated Milan
Marta Fusco Linklaters Other Not stated Not stated
Giorgio Valoti Linklaters Other Not stated Not stated
Jacopo Cislaghi Linklaters Associate Not stated Not stated

Stated terms

Stated value
EUR 750m (€750m)
What the figure measures
Issue size
Client
Linklaters
Counterparties
Neopharmed Gentili (Issuer)